Arkolith/Insider Trading/SCTX/Form 4

Orbimed Advisors LLC

DirectorScribe Therapeutics, Inc. (SCTX) · full profile →Form 4 · filed Jul 29, 2026
Net Buying
Open-Market Buys
$15.0M
Open-Market Sells
$0
Net Open-Market Flow
$15.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 27, 2026Conversion(C)349K——349K
Jul 27, 2026Buy(P)1.0M$15.00$15.0M1.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 27, 2026Conversion(C)2.1M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-26-000733) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML